Drug Topics

MARCH 24, 2023

New research examines how individuals with continuing COVID-19 symptoms are managing the virus.

402

402

PharmaVoice

MARCH 24, 2023

How life science execs would transform clinical trials with a little hocus pocus.

246

246

Drug Topics

MARCH 24, 2023

Survey respondents indicated a lack of comfort around recommending psilocybin therapy to patients.

247

247

STAT

MARCH 24, 2023

I am by no means telepsychiatry’s biggest fan. But since March 2020, when my practice of outpatient psychiatry changed overnight, I have adapted to it. I have learned to get up between appointments so I don’t sit in front of a computer all day and how to fit in patient visits while on a work trip. I still prefer being in the actual room with a patient, but I accept this is the way my job looks now.

145

145

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

MARCH 24, 2023

About 1 in 10 individuals in the United States have diabetes. A recent study examines how much they are paying on average for access to treatment for the common disease.

247

247

Fierce Healthcare

MARCH 24, 2023

Instacart reaches deal with Boston Children's to help deliver nutritious meals to patients rking Fri, 03/24/2023 - 15:18

128

128

Fierce Healthcare

MARCH 24, 2023

AHA: MedPAC report on hospital finances 'misleading;' recommended 2024 pay bump 'totally insufficient' dmuoio Fri, 03/24/2023 - 15:39

Hospitals 110

Hospitals 110

Drug Topics

MARCH 24, 2023

All children included in the analysis with presymptomatic SMA achieved swallowing, oral nutrition, and airway protection outcomes.

247

247

European Pharmaceutical Review

MARCH 24, 2023

Following the recent announcement of topline results from 89bio’s Phase IIb trial, ENLIVEN, evaluating FGF21 analogue pegozafermin for nonalcoholic steatohepatitis (NASH), a serious liver condition, EPR spoke with Dr Hank Mansbach, the company’s Chief Medical Officer. NASH currently has no approved treatments. Caused by excess fat, it is referred to as the ‘silent killer’, as most affected individuals don’t exhibit symptoms until liver damage has already occurred.

108

108

Drug Topics

MARCH 24, 2023

Rural communities are often left without adequate assistance in times of need, but pharmacists can provide crucial care.

247

247

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Drug Store News

MARCH 24, 2023

+PlusCBD Daily Balance THC-Free products provide the benefits of CBD without the effects of THC, the company said.

106

106

Fierce Healthcare

MARCH 24, 2023

UnitedHealthcare study: College students more likely to face mental health needs than parents think pminemyer Fri, 03/24/2023 - 16:42

106

106

Fierce Pharma

MARCH 24, 2023

Sanofi, Regeneron's Dupixent could hit $20B in peak sales with COPD expansion: analyst kdunleavy Fri, 03/24/2023 - 07:30

101

101

STAT

MARCH 24, 2023

LAWRENCE, MASS. — Herman Quintero was cracking jokes about the lottery, touching just below his right eye for luck. It came down to the Mega Millions to pay the medical bill he pulled up on the Patient Gateway app on his phone. Or somebody lending a hand, he said, eyes puckish as they peered out from under a navy blue Tigers baseball cap — a relic of his years working on a car assembly line in Detroit — and over at the Digital Access Coordinator sitting beside him.

Hospitals 100

Hospitals 100

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Healthcare

MARCH 24, 2023

Providers want CMS to create new payment methods to boost primary care rking Fri, 03/24/2023 - 17:17

99

99

The Thyroid Pharmacist

MARCH 24, 2023

One of the most discouraging symptoms I began experiencing before receiving my Hashimoto’s diagnosis was that I began losing my memory. In school, I always had a strong memory, and prided myself on my ability to recall obscure facts and details from experiences I’d had many years earlier. Once my Hashimoto’s symptoms increased, however, my brain became “fuzzy”… and I frequently had a hard time remembering even common words mid-sentence (“You know, that animal with the fur?

Compounding 98

Compounding Immunization Dosage Adverse Reactions 98

STAT

MARCH 24, 2023

In a setback to GSK, a California judge ruled that a consumer cleared a key legal hurdle and can proceed with a lawsuit claiming the Zantac heartburn drug was linked to cancer, a decision that suggests the company may face lengthy and expensive litigation. The ruling stands in contrast to a decision issued last December by a U.S. federal judge in Florida, who was overseeing a separate batch of lawsuits and determined that claims the medicine can cause several different types of cancer were not b

98

98

DiversifyRx

MARCH 24, 2023

The interest in compounding has definitely increased recently. Use these 5 proven strategies to grow your compounding prescriptions and profits. I love compounding. It was my first passion in pharmacy. For me, every potential compounding patient is a problem that needs solving. Big pharma medicine can help most people but can’t help everyone or every problem.

Compounding Pharmacies 98

Compounding Pharmacies Compounding Independent Pharmacies 98

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

STAT

MARCH 24, 2023

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.   That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

98

98

The Checkup by Singlecare

MARCH 24, 2023

When toddlers start sniffling, sneezing, and coughing, most parents assume they’ve picked up a cold or another respiratory virus. But when these symptoms linger for longer than the average illness, consider an environmental allergy. “An allergy is an inappropriate or exaggerated response of the immune system when exposed to something,” says Adrianna Bravo , MD, a pediatrician and senior medical adviser for Inspire Diagnostics.

Immunization 98

Immunization 98

Drug Store News

MARCH 24, 2023

Mi Súper Dollar General was developed with a customer-first focus, tailor-made to help consumers find great prices and convenient shopping experiences for all of their needs.

98

98

European Pharmaceutical Review

MARCH 24, 2023

AstraZeneca has announced the first and only dual-combination inhaled corticosteroid and long-acting beta2-agonist (ICS/LABA) treatment for mild asthma has been approved in the UK. The marketing authorisation has been given to budesonide/formoterol (Symbicort Turbohaler 200/6) as a reliever therapy for patients over 12 years old. The combination therapy, delivered as a formulation in a single inhaler contains b udesonide, an inhaled corticosteroid (ICS) and f ormoterol, a long-acting beta2-agoni

97

97

Drug Store News

MARCH 24, 2023

The proposed Abatacept biosimilar is a dual biologic intended to suppress neuroinflammation via multiple immunomodulatory pathways, for the treatment of neurodegenerative conditions.

98

98

European Pharmaceutical Review

MARCH 24, 2023

The European Medicines Agency (EMA) has published a report summarising the mid-point achievements of its Regulatory Science Strategy (RSS) to 2025. Initially published in March 2020, the strategy provides a plan for advancing regulatory science over a five-year period. Regulatory science refers to the scientific disciplines that are applied to the quality, safety and efficacy assessment of medicinal products.

96

96

Drug Store News

MARCH 24, 2023

The fly-in will focus on ways community pharmacies can serve their constituents and what changes to the payment model are needed to best care for them in the future.

Community Pharmacies 97

Community Pharmacies 97

Pharmaceutical Commerce

MARCH 24, 2023

Pharma Commerce offers a synopsis of some of the conference’s events.

96

96

Drug Store News

MARCH 24, 2023

Containing fruity and citrus flavors, the company is debuting seasonal foods across its Pillsbury and Cheerios lines.

95

95

Pharmafile

MARCH 24, 2023

NeuroRPM has announced that it has received clearance from the FDA for its NeuroRPM device which uses AI and existing Apple Watch technology to monitor symptoms of Parkinson’s disease, offering continuous, day-to-day tracking of symptoms.

FDA 90

FDA Communication 90

Fierce Pharma

MARCH 24, 2023

GSK plays defense after California judge approves plaintiff's expert testimony in high-stakes Zantac trial fkansteiner Fri, 03/24/2023 - 10:05

90

90

Drug Store News

MARCH 24, 2023

The Independent Grocery Strategy Series webinars are slated for April, May and June.

89

89

Fierce Pharma

MARCH 24, 2023

Brii Bio shelves once-promising COVID antibody combo that stood up to variants kdunleavy Fri, 03/24/2023 - 10:07

79

79

BioPharm

MARCH 24, 2023

Curia is collaborating with Corning to advance biopharmaceutical continuous-flow development and manufacturing programs.

74

74

Fierce Pharma

MARCH 24, 2023

Time to pay Daniel O'Day: Gilead chief nabbed nearly $22M after strong showings in HIV, cancer fkansteiner Fri, 03/24/2023 - 08:56

66

66